EMEA-003367-PIP01-22 - paediatric investigation plan

nizaracianine triflutate

Key facts

• Active substance:
  nizaracianine triflutate
• Therapeutic area:
  Diagnostic
• Decision number:
  P/0271/2023
• PIP number:
  EMEA-003367-PIP01-22
• Pharmaceutical form(s):
  Powder for solution for injection
• Route(s) of administration:
  Intravenous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  14/07/2023
• Compliance check done:
  No

Decision

P/0271/2023 : EMA decision of 14 July 2023 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for nizaracianine triflutate (EMEA-003367-PIP01-22)

Reference Number: EMA/251128/2023